Bicara Therapeutics
BCAX
#7214
Rank
NZ$1.02 B
Marketcap
NZ$15.43
Share price
-7.46%
Change (1 day)
-51.98%
Change (1 year)

EPS for Bicara Therapeutics (BCAX)

EPS in 2026 (TTM): NZ-$5.39

According to Bicara Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$5.67. In 2025 the company made an earnings per share (EPS) of NZ-$4.62 an increase over its 2024 EPS that were of NZ-$4.68.

EPS history for Bicara Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$5.3916.56%
2025NZ-$4.62-1.21%
2024NZ-$4.68